The fund run by the world’s oldest active institutional investor has made public its 13-F filing for the first quarter of 2013. The company shows $678,710,208 under management at the end of the first quarter in this filing, which only covers long equity bets, compared to $576,176,273 at the end of 2012. In this quarter, some of the company’s biggest bets made up the majority of the long portfolio. Merck & Co., Inc. (NYSE:MRK) shares were held to a value of $51,478,048; Citigroup Inc (NYSE:C) shares were valued at $60,871,275; and Pfizer Inc. (NYSE:PFE) holdings were valued at $74,240,493. Those…
On This Page
This content is exclusively for paying members of Hedge Fund Alpha
Insider Strategies and Letters to Shareholders from the Top Hedge Funds and Maximize Your Portfolio Growth with Hedge Fund Alpha
Don’t have an account?
Subscribe now and get 7 days free!
